Skip to main content
. 2018 Jul 5;2018:3565292. doi: 10.1155/2018/3565292

Figure 6.

Figure 6

Pharmacological inhibition of Dll4 in OIR using soluble Dll4-Fc fusion protein (b) ameliorates pathological retinal neovascularization and improves normal retinal revascularization in the OIR model [33]. Yellow arrows indicate pathological neovascular tufts.